Charleston, SC -- (SBWIRE) -- 10/28/2013 -- otcstockcenter.com provide information specifically for trades in the micro-cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Let’s have a look on Few Hot Stocks: Zogenix, Inc. (NASDAQ:ZGNX), Biogen Idec Inc (NASDAQ:BIIB), Clovis Oncology Inc (NASDAQ:CLVS), Fusion-IO, Inc. (NYSE:FIO).
Zogenix, Inc. (NASDAQ:ZGNX) opened the session at $3.39, trading in a range of $3.18 - $3.44, and was at $3.25. The stock showed a positive performance of 6.91% in the recent trading session. The stock was trading on a volume of 3.39 million shares and the average volume of the stock remained 1.30 million shares at 10:05 AM. Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.
For How Long ZGNX will fight for Profitability? Find Out Here
Biogen Idec Inc (NASDAQ:BIIB) was moving on trading-volume of 711.906 shares in the recent trading session versus its average trading volume of 1.11 million shares. The share price advanced 1.52% and reached at $256.10. The market capitalization of the stock remained 60.95 billion. YTD trend of the stock was positive 75.34%. Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.
For How Long BIIB Gloss will Attract Investors? Find Out Here
Clovis Oncology Inc (NASDAQ:CLVS) was trading with a volume of 224.272 shares versus the average volume of the stock 555.263 shares. The stock grew 11.00% and was recently trading at $63.11. The market capitalization of the stock remained 1.91 billion. Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally.
Will CLVS Continue To Move Higher? Find Out Here
In the current trading day, Fusion-IO, Inc. (NYSE:FIO) enhanced 15.93% to move at $11.05. The volume of the stock was 2.65 million shares and the average volume remained 4.00 million shares. The stock, at last check, has the day price range of $9.83 - $11.08. The market capitalization was recorded at 1.13 billion. Fusion-io, Inc. develops, markets, and sells storage memory platforms in the United States and internationally.
Why Should Investors Buy FIO After The Recent Gain? Find Out Here
About OTC Stock Center:
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)